Objective: To describe fasting plasma total-and lipid standardised-vitamin E and ascorbate concentrations in Hong Kong Chinese subjects, and to explore age-, diet-and sex-related differences. Design: Observational study. Setting: Hong Kong. Subjects: One hundred and ®fty randomly selected Chinese subjects. Interventions: Fasting plasma concentrations of ascorbate, total vitamin E and lipid standardised vitamin E (Vit E LS , expressed as mmol vitamin Eammol total cholesterol plus triglycerides) were measured. Results: Total vitamin E concentrations ranged from 6 ± 53 mmolal (mean 24; s.d. 8.5), and Vit E LS from 0.85 ± 7.09 mmolammol (mean 3.61; s.d. 1.19). Plasma Vit E LS concentrations in women were higher (P 0.02) than in men: mean (median) concentrations 3.82 (3.88) and 3.37 (3.28) mmolammol, respectively. Vit E LS concentrations in men decreased with age. Mean (s.d.) plasma ascorbate concentrations in men and women were 49.7 (14.0) and 51.6 (21.6) mmolal respectively, and did not show the signi®cant age-and sex-differences reportedly found in Western studies. Conclusions: The hypothesis that Hong Kong Chinese, with their low risk of CHD, might have high Vit E LS levels in fasting plasma is not supported by the results obtained. Moreover, results showed male±female differences and, in men, a previously unreported age-related decrease in plasma Vit E LS concentration which cannot be accounted for by concomitant differences in dietary intake of vitamin E alone. Results also suggest that the age-and sex-differences in plasma ascorbate seen in Western populations can be avoided by increased vitamin C intake. Sonsorship: This work was ®nancially supported by The Hong Kong Polytechnic University and the UK/HK Joint Research Scheme.
Introduction
Vitamin E is the generic name given to a group of biologically active, lipid soluble antioxidant compounds, the tocopherols and tocotrienols (Traber & Packer, 1995; Cohn, 1997) . Owing to the very small amount of trienols and`non-alpha' tocopherols in fasting plasma, the concentration of`vitamin E' is regarded as practically equivalent to that of alpha tocopherol in fasting plasma, and, although not entirely correct, these terms are often used synonomously. Ascorbate is a water soluble antioxidant of major importance (Frei et al, 1989) . A redox interaction between these vitamins has been proposed, the lipid bound vitamin E being recycled from its oxidised tocopheroxyl radical form by ascorbate in the aqueous surroundings (Thomas et al, 1995) .
Ascorbate and vitamin E levels in plasma do not usually directly re¯ect simple dietary intake (Bates, 1997; Benzie & Strain, 1997; Cohn 1997) . Plasma levels of vitamin E are, however, directly increased by supplemental intake (Weber et al, 1997) , and this is, in turn, associated with an increase in the resistance of low density lipoprotein (LDL) to oxidation (Esterbauer & Jurgens, 1993; Jialal & Devaraj, 1996) . Vitamin E might, therefore, help lower risk of coronary heart disease (CHD) by decreasing formation of highly atherogenic oxidised LDL, as well as by virtue of other anti-atherogenic properties (Ferns et al, 1993; Halliwell, 1995; Jialal et al, 1995; Benzie, 1996a; Berliner & Heinecke, 1996; Maxwell & Lip, 1997) . The strong inverse correlation found between plasma vitamin E concentrations, or intake, and CHD mortality is consistent with this (Riemersma et al, 1990; Rimm et al, 1993; Stampfer et al, 1993; Bellizi et al, 1994; Par®tt et al 1994; Gey, 1995) . There are, however, con¯icting reports of age-related changes, and there is a reported lack of male±female differences in plasma vitamin E concentrations (Vandewoude & Vandewoude, 1987; Succari et al, 1991; Frei, 1995; Machlin, 1995) , although subjects with higher plasma lipid levels exhibit higher vitamin E levels (Duthie et al, 1993) . These observations are not consistent with the proposed CHD protective effect of vitamin E. Diets rich in ascorbate are bene®cial, but whether this is cause or coincidence is not yet clear (Block et al, 1992; Frei, 1995; Machlin, 1995) . Furthermore, results of intervention studies involving dietary supplementation with antioxidant vitamins have not so far shown convincing evidence of a subsequent signi®cant decrease in CHD risk (Rapola et al, 1996; Stephens et al, 1996; Maxwell & Lip, 1997; Weber et al, 1997 Health, 1997) , low when compared to European populations. Cholesterol and triglycerides concentrations are not, however, concomitantly low. In a population wide study of 2900 individuals aged 25 ± 74 y, 46% of men and 41% of women had plasma cholesterol levels of ! 5.2 mmolal; 12% of men and 13% of women had plasma cholesterol levels ! 6.2 mmolal. These proportions increased with age (Janus et al, 1997). Plasma ascorbate and vitamin E concentrations in Hong Kong Chinese have not been previously reported. Based on European studies (Gey et al, 1991; Gey, 1995; Winklehoffer-Roob et al, 1997) , however, our hypothesis was that plasma lipid standardised vitamin E (Vit E LS ) would be high in this population. The aims of this study, therefore, were to determine plasma vitamin E concentrations in Hong Kong Chinese and to test for age-related and male±female differences in vitamin E levels. Plasma ascorbate concentrations were also investigated, and plasma levels of both ascorbate and vitamin E were related to recently published dietary data (Leung et al, 1997) .
Materials and methods

Samples
Samples used were fasting, non-haemolysed, EDTA plasma samples from 150 (78 women, 72 men) apparently healthy, consenting, free-living normal Chinese aged 21± 70 y from a range of socio-economic backgrounds and geographical areas in Hong Kong. This was an unselected subsample from a study (Janus et al, 1997) of coronary heart disease risk factors in 2900 subjects recruited by telephone interview using randomly generated telephone numbers. This method of subject recruitment is well validated in Hong Kong, where telephone accessibility is not linked with socio-economic status. Blood was kept chilled and in the dark until separation of plasma, which was within three hours of sampling. Plasma was then stored at 7 70 C until assayed for lipids and vitamin E, with no intermediate thawing/refreezing. Ascorbate measurements on whole plasma were performed immediately after separation. Ethical approval for this study was obtained from the Ethics Committees of both the Hong Kong Polytechnic University and University of Hong Kong; all procedures involving human subjects complied with the Declaration of Helsinki as revised in 1989.
Test procedures
Vitamin E was measured by a¯uorimetric method (Hansen & Warwick, 1969) , using pure ( b 98%) DL-alpha-tocopherol (Merck, Darmstadt, Germany) as calibrator. In-run CVs on plasma samples at 24 and 44 mmolal were 2.0% (n 10 in each case). Between-run CV on plasma samples was 7.1% (mean 33 mmolal, n 13). Recovery of alpha tocopherol added to plasma was 83 ±110% (mean 93%; CV 9.0%, n 18). Lipid standardised vitamin E was expressed as mmol vitamin E per mmol of total cholesterol plus triglycerides (Thurnham et al, 1986) . Total cholesterol and triglycerides concentrations in plasma were measured using enzymatic methods (Roche Diagnostic Systems, Switzerland) on a Cobas Fara centrifugal analyser (Roche). In 139 of the 150 freshly separated whole plasma samples ascorbate was measured using a speci®c enzyme assisted spectrophotometric method known as EFTSA (Benzie, 1996b) , on a Cobas Fara centrifugal analyser; freshly prepared aqueous solutions of ascorbate (from extra pure ascorbic acid, Merck) were used as calibrators; within-and between-run CVs were`5% at 25, 50, 100 and 440 mmolal, n ! 10 in each case. Statistical analysis of results for age-and sex-related differences used the Mann ± Whitney non-parametric test. Comparison of population dietary data was performed using Welch's approximate t-test.
Results
Plasma Vit E LS concentrations were lower than expected, and showed a male±female difference not previously reported. Concentrations ranged from 6 ±53 mmolal (mean 24; s.d. 8.5) for total vitamin E; 0.85± 7.09 mmolammol total cholesterol plus triglycerides (mean 3.61; s.d. 1.19) when lipid standardised (Table 1) . As expected there was a signi®cant, direct correlation between plasma total vitamin E and lipid concentrations (results not shown). However, while total vitamin E increased with lipid concentrations, hyperlipidaemic subjects tended to have lower concentrations of Vit E LS (Figure 1 ; r 7 0.259; P 0.0013).
A signi®cant, direct correlation was found between age and total vitamin E (results not shown), most probably owing to the age-associated increase in lipid levels. Women had similar total vitamin E concentrations to men. Vit E LS concentrations of women, however, were signi®-cantly (P 0.02) higher than those of men (Table 1) . Figure 2 shows mean s.e.m. plasma Vit E LS concentrations in men (diagonal lines) and women (horizontal lines) across 10 y age groups. Results showed that, while Vit E LS concentrations in men and women were very similar in the youngest age group (21 ± 30 y), men aged b 30 y had slightly lower plasma Vit E LS than age-matched women. a Signi®cantly different from male value; P 0.02. Figure 1 Relationship between plasma cholesterol plus triglycerides concentration and lipid standardised vitamin E concentration (r 7 0.259; P 0.0013).
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Figure 2
Comparison of the mean ( s.e.m.) plasma lipid standardised vitamin E concentration in men (diagonal lines) and women (horizontal lines) across 10 y age groups. Men aged b 30 y had consistently lower levels than women of similar age, although statistical signi®cance was reached only in the 51 ± 60 y age group (P 0.046).
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Comparing 21 ±40 and 41± 60 y age groups, older men had signi®cantly (P 0.001) lower plasma Vit E LS concentrations.
To explore possible methodological effects in relation to the lower than expected vitamin E levels found, a small (n 10; 4 females, 6 males) sample of Caucasians living in Hong Kong was studied. Results of this pilot study revealed mean (median) total and lipid standardised vitamin E concentrations in the fasting plasma of Caucasians of 33.2 (31.0) mmolal and 4.50 (4.48) mmolammol respectively, signi®cantly (P`0.01) higher than those obtained, using the same analytical methods and conditions, in the fasting plasma of Chinese subjects. These data imply that the lower Vit E LS concentration obtained in our Chinese subjects, compared to those previously published for European subjects, was not owing to analytical differences between the current study and the European studies.
Fasting plasma ascorbate concentrations of the Chinese men and women studied were similar (Table 1) , and showed no age-related effects.
Discussion
The novel ®nding that women have higher plasma Vit E LS concentrations than men deserves further study, but is consistent with observations of dietary intake of vitamin E in Hong Kong adults (Leung et al, 1997) . While intake of vitamin E is generally higher in men than women (Weber et al, 1997) , when expressed as mg/kcal nutrient intake, average vitamin E intake of Hong Kong Chinese women (5.8 mg/kcal) is signi®cantly (P`0.01) higher than that of men (4.7 mg/kcal). This may help explain the male±female difference in plasma levels reported here.
Age-related decreases in plasma Vit E LS concentrations seen in men also warrant further study, particularly as these are not associated with parallel age-related differences in vitamin E intake. Indeed, in Hong Kong men (but not women), dietary intake of vitamin E increases with age (Leung et al, 1997); mean (s.d.) vitamin E intake of men aged ! 55 y is reported to be 5.22 (2.09) mg/kcal, signi®-cantly (P`0.0001) higher than that of men aged 34 y (4.05 (1.14) mg/kcal).
With reference to ascorbate concentrations in Hong Kong Chinese, no male±female difference was found, and older subjects did not show lower concentrations. This contrasts with the reportedly well established ®nding in Western populations that women have generally higher plasma ascorbate concentrations than men, and that elderly people have generally lower levels than younger people (Bates, 1997) . However, there is no clear physiological mechanism to account for sex-and age-related differences, and these are likely to be caused, at least in part, by different dietary habits (Bates, 1997) . There may, however, be higher rates of ascorbate utilisation in men and in older subjects, possibly related to increased urate levels (Benzie & Strain, 1996) , and to subclinical age-related disease. The absence of detectable sex-and age-related effects on plasma ascorbate concentrations in this current study could be owing to relatively high vitamin C dietary intakes in the local Hong Kong population: mean (s.d.) intakes are 60 (35) and 94 (54) mg per 1000 kcal per day for men and women respectively (Leung et al, 1997) . These ®gures are signi®cantly (P`0.001) higher than those reported in UK men and women (28 (17) and 38 (26) respectively) (Gregory et al, 1990). Furthermore, vitamin C intake in Hong Kong increases with age, rising from a mean (s.d.) intake, in men, of 48 (26) mg per 1000 kcal at age 34 to 73 (43) (P`0.0001) at age ! 55 y, and from 88 (53) to 104 (61) mg per 1000 kcal for women (P`0.05) in the same age groups (Leung et al, 1997) . It is possible that putative age-and sex-related differences in ascorbate demand are more than matched by the dietary supply, preventing the sex-and age-related differences in plasma ascorbate seen in populations whose dietary intake of vitamin C is relatively poor.
It must be noted that, while the dietary data are assumed to be representative of the subjects in this current study, the data on dietary intake of ascorbate and vitamin E were collected from a representative 1010 subjects from a study total of 2900 participants (Leung et al, 1997) , while the plasma vitamin levels were measured on 150 subjects randomly selected from the 2900 study participants. There may have been some overlap between the subsamples, but results must be interpreted with this reservation in mind. Having clari®ed this, however, it must also be noted that plasma ascorbate and vitamin E concentrations are not simply a function of dietary intake. Ascorbate status of plasma is affected by the form in which the vitamin is ingested, stability, size of dose, renal loss and rate of utilisation (Bates, 1997; Benzie & Strain, 1997) . Various factors, including the isomeric form of dietary vitamin E (Traber, 1994) , the amount of PUFA in the diet (Weber et al, 1997) , the rate of irreversible oxidation of the vitamin (Schultz et al, 1995) , the rate of release from adipose tissue stores and, possibly, in vivo redox recycling of the alpha tocopheroxyl radical (Niki, 1987; Bowry et al, 1995) , help de®ne vitamin E status of plasma.
In this context, it may be signi®cant that Hong Kong Chinese women of all age groups have a higher daily intake of vitamin C and a lower intake of PUFA (approximately 20% lower) than men (Leung et al, 1997) . Moreover, women generally have greater adipose tissue mass than men, and are likely, therefore, to have concomitantly greater vitamin E stores. These factors may be important contributors to the higher plasma vitamin E levels seen in women in this study and, possibly, to their lower CHD risk.
This study has also shown that fasting plasma Vit E LS concentrations of apparently healthy Hong Kong Chinese are similar to those of European populations with a considerably higher CHD mortality rate (Gey et al, 1991) . The very strong inverse relationship between plasma vitamin E and CHD risk found in European studies (Gey et al, 1991; Gey, 1995) , therefore, does not appear to apply to this population. Average daily vitamin E intake in Hong Kong Chinese is 11.22 mg and 10.47 mg for men and women respectively (Leung et al, 1997) . This is similar to intakes of men in UK (11.7 mg/d) and in the US (10.0 mg/d), and slightly higher than those reported for women in UK (8.6 mg/d) and US (7.6 mg/d) (Gregory et al, 1990; Alaimo et al, 1994) . Relationships between dietary intake and plasma levels of vitamin E, and between vitamin E levels and CHD risk in Hong Kong Chinese, therefore, may be different from those in European populations. This may re¯ect other important, as yet unexplored, dietary and other factors which may modulate CHD risk.
Conclusions
The hypothesis that Hong Kong Chinese, with their low risk of CHD, might have high lipid standardised vitamin E levels in fasting plasma is not supported by the results obtained. Moreover, results showed male±female Plasma ascorbate and vitamin E levels IFF Benzie et al differences and, in men, an age-related decrease in plasma Vit E LS concentrations not previously reported. Furthermore, the absence of sex-and age-related differences in plasma ascorbate concentrations suggests that such differences, reportedly commonly found in Western populations, may be prevented by increased vitamin C intake. The results also highlight the importance of the various factors which determine vitamin E status, and the overall complexity of CHD risk assessment.
